
PeerView Endocrinology & Diabetes CME/CNE/CPE Video Podcast
by PVI, PeerView Institute for Medical Education
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇸🇦SA · Science#123500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
250 to 1.5K🎙 ~2x weekly·50 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
500 to 3K🇸🇦100% - Active Followers
Loyal subscribers who consistently listen
150 to 900
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 15 epsHosts
Not detected.
Recent guests
Recent episodes
Christie M. Ballantyne, MD, MNLA, FACP, FACC, Jessica M. Peña, MD, MPH, FACC, FNLA, FAHA - Combining Our Efforts for Patients With High-Risk ASCVD: Applying New Guidelines to Address the Challenge of Lipid Management
Jul 13, 2026
57m 21s
Javier Morales, MD, FACP, FACE - Bridging Knowledge to Action: Translating Evidence Into Practice for Type 2 Diabetes Management
Jul 8, 2026
1h 03m 51s
Athena Philis-Tsimikas, MD - Betting on Basal Insulin: Case Studies in Improving the Odds for People With Type 2 Diabetes
Jun 25, 2026
34m 46s
Athena Philis-Tsimikas, MD - Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes (Updates From Las Vegas)
May 25, 2026
1h 08m 39s
Christina Y. Weng, MD, MBA - Reimagining Retinal Treatment: The Promise of Novel Delivery Mechanisms for Anti-VEGF Therapies
May 12, 2026
35m 36s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/13/26 | ASCVDlipid management+3 | Christie M. Ballantyne, MD, MNLA, FACP, FACCJessica M. Peña, MD, MPH, FACC, FNLA, FAHA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | ASCVDlipid management+3 | Merck & Co., Inc. | 57m 21s | ||
| 7/8/26 | Type 2 Diabetes ManagementEvidence-Based Practice+3 | Javier Morales, MD, FACP, FACE | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Type 2 DiabetesCME+4 | Lilly | 1h 03m 51s | ||
| 6/25/26 | Type 2 DiabetesBasal Insulin+3 | Athena Philis-Tsimikas, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Type 2 DiabetesBasal Insulin+4 | Lilly | 34m 46s | ||
| 5/25/26 | basal insulintype 2 diabetes+3 | Athena Philis-Tsimikas, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | basal insulintype 2 diabetes+4 | Lilly | 1h 08m 39s | ||
| 5/12/26 | retinal treatmentanti-VEGF therapies+3 | Christina Y. Weng, MD, MBA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+3 | — | retinal treatmentanti-VEGF+4 | Genentech | 35m 36s | ||
| 5/7/26 | Incretin-based therapiesType 2 diabetes+3 | Jay H. Shubrook, DO, FAAFP, FACOFP | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | incretinType 2 diabetes+6 | Lilly | 1h 25m 04s | ||
| 4/3/26 | Type 2 DiabetesBasal Insulin+3 | Prof. Chantal Mathieu, MD, PhD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Type 2 DiabetesBasal Insulin+3 | Lilly | 1h 07m 20s | ||
| 3/24/26 | retinal vascular diseasespatient outcomes+3 | Peter A. Campochiaro, MDDiana V. Do, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | retinal diseasespatient care+5 | Regeneron Pharmaceuticals, Inc. | 57m 25s | ||
| 11/20/25 | Type 2 DiabetesCardiovascular Risk+3 | John B. Buse, MD, PhDPam R. Taub, MD, FACC, FASPC | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | glycemiacardiovascular risk+6 | Lilly | 1h 03m 31s | ||
| 10/30/25 | patient careobesity+3 | Arun J. Sanyal, MBBS, MD | PVI, PeerView Institute for Medical EducationObesity Medicine Association+3 | — | CMEhealthcare professionals+3 | Boehringer Ingelheim Pharmaceuticals, Inc. | 44m 00s | ||
| 10/27/25 | ObesityPsoriatic Arthritis+3 | Alexis Ogdie, MD, MSCERobert H. Eckel, MD, FAHA, FACC | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | obesitypsoriatic arthritis+4 | Lilly | 56m 09s | ||
| 7/21/25 | Diabetic RetinopathyDiabetic Macular Edema+3 | Joseph M. Coney, MD, FACS, FASRS | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+3 | — | diabetic retinopathydiabetic macular edema+3 | Genentech | 50m 39s | ||
| 5/6/25 | Type 2 DiabetesPatient Empowerment+3 | Professor Melanie Davies | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Type 2 DiabetesPatient Care+5 | Lilly | 59m 29s | ||
| 4/1/25 | obesity managementpatient care+3 | Professor Carel le RouxDonna H. Ryan | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | obesitypatient care+3 | Lilly | 1h 02m 40s | ||
| 3/19/25 | obesity managementhealthcare education+4 | Angela Fitch, MD, FACP, FOMA | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | obesityhealthcare professionals+8 | Lilly | 1h 05m 15s |
Showing 15 of 15
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for PeerView Endocrinology & Diabetes CME/CNE/CPE Video Podcast
Peaked at #123 in SA, currently #123 in SA.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| SA | — | #123 | #123 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.